| Aug 19 |
FDA lifts partial hold on study of BioNTech-partnered ADC
|
| Aug 19 |
Pfizer and BioNTech's Combo Shot Missed the Mark. Is It Time to Sell?
|
| Aug 17 |
FDA is said to clear updated COVID shots as early as next week
|
| Aug 16 |
Pfizer and BioNTech’s Covid-19/flu combination vaccine falters in Phase III readout
|
| Aug 16 |
Pfizer, BioNTech hit roadblock in COVID-flu vaccine trial
|
| Aug 16 |
Pfizer, BioNTech Combination Flu and COVID-19 Shot Misses 1 of 2 Endpoints
|
| Aug 16 |
Pfizer’s Stumble on Flu and Covid Shot Is a Plus for Moderna
|
| Aug 16 |
Pfizer Slides Toward Sell Zone After BioNTech-Tied Covid/Flu Shot Misses Its Mark
|
| Aug 16 |
Update: BioNTech Shares Fall as Phase 3 Trial of Combined Influenza, COVID-19 Vaccine With Pfizer Misses 1 of 2 Immunogenicity Targets
|
| Aug 16 |
Pfizer, BioNTech stumble in effort to develop combination flu, COVID shot
|
